undamentalytics Newsletter
Sign in

Celcuity Inc. (CELC) stock

Add to watchlist

Add holding +

NASDAQ: CELC Nasdaq Biotechnology Next results ~November 5, 2026

Celcuity Inc. is a US-listed company in the biotechnology industry. Its financial year ends in December.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 3 selling0 purchases and 17 sales by directors and officers, last 12 monthsInsider trades
  • Funds166 adding, 137 cuttingOf 59 active managers that changed their stake, 31 added; quarter to June 30, 2026Fund buyers and sellers

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Current signal Share count rising (dilution): Diluted shares outstanding rose 21.5% year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Results due soon. Results are expected around 11 November; the share price can move sharply on the day.
  • Share dilution. Diluted shares rose 21.5% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 63% and a beta of 1.0 against the S&P 500.
  • Insiders selling. 3 insiders sold $328M of stock over the past 365 days and none bought (3% under pre-set trading plans).
  • Heavily shorted. 31.4% of the shares available to trade are sold short (7.4 days of average volume to cover).
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 110.8% over 90 days.

Latest results

Earnings per share
-$1.07 against an average estimate of -$1.08: beat by 0.9%
Share reaction
-0.1% in the first session after the results on August 13, 2026, against +0.5% for the S&P 500
Next report
November 5, 2026; average EPS estimate -$1.51

Celcuity's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-3.0%
  • 1 week+1.9%
  • 1 month-7.0%
  • This year-32.8%
  • 1 year-13.1%
  • 5 years+246.6%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

EPS (TTM, diluted)
$-4.32

Growth

Share count change
+21.5%

Earnings

Last results
August 13, 2026
Next results (est.)
November 11, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Announcement
  3. Announcement
  4. Results
  5. Announcement
  6. Insider trade

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Celcuity Inc. valuation models and calculator

No model value for Celcuity Inc. at the moment. Current status: limited reported history: available models are shown without a Buy/Hold/Sell rating. Available reported financials are shown below.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Valuation models

We value Celcuity Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.3%: the 10-year Treasury yield (4.9%) plus a beta of 0.74 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: book value or earnings not available
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. — Does not apply: no positive revenue in the latest twelve months
Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. — No model applies: the filings don’t yet support a value.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Celcuity Inc. with Biotechnology in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, after the close. Analysts expect revenue of $1m and EPS of −$1.51 (range −$1.60 to −$1.42) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$4.39 −36% $24m 0%
Next −$0.08 +98% $316m +1218%

Next year's EPS estimate has moved −110.8% in 90 days, across 2 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +24.4% on 90 days ago. In the last 30 days, 0 analysts raised Celcuity Inc.'s forecast and 2 cut it.

Consensus EPS forecast Celcuity Inc., last 90 days
−$6.00 −$4.00 −$2.00 $0.00 $2.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$3.53 Current fiscal year, 60 days ago: −$3.53 Current fiscal year, 30 days ago: −$3.77 Current fiscal year, 7 days ago: −$3.77 Current fiscal year, Now: −$4.39 −$4.39 Next fiscal year, 90 days ago: $0.74 Next fiscal year, 60 days ago: $0.74 Next fiscal year, 30 days ago: $0.96 Next fiscal year, 7 days ago: $0.96 Next fiscal year, Now: −$0.08 −$0.08

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$3.53$0.74
60 days ago −$3.53$0.74
30 days ago −$3.77$0.96
7 days ago −$3.77$0.96
Now −$4.39−$0.08

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$1.08 −$1.07 +0.9%
Mar 2026 −$0.89 −$0.86 +3.4%
Dec 2025 −$1.01 −$0.73 +27.7%
Sept 2025 −$0.96 −$0.78 +18.5%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

13 analysts, Oct 2026
Buy13100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202631013
  2. Sep 20263912
  3. Aug 202621012
  4. Jul 202621012

Counts of recommendations published by analysts covering Celcuity Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
31.4%
of tradable shares
Days to cover
7.39
at average volume
Short interest, 1 month
−10%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
10.2%
of shares
Employees
155
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CELC+44%+6%+4%−10%+662%−33%
Industry peers (median)−36%−57%−18%−29%−5%−26%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CELC42%42%50%67%58%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CELC−61%−60%−38%−44%−40%−61%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since September 20, 2017: 86% from September 20, 2018 to April 16, 2020. Getting back needed a 596% gain, reached on June 28, 2021, 438 days after the low.

Price behaviour

52-week range
$56.58 – $144.98
From 52-week high
−53.7%
vs 50-day average
−13.1%
vs 200-day average
−33.2%
Volatility (1 year)
63%
Beta vs S&P 500
1.04

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±8.7%
After a week
6 up, 6 down
typical move ±9.7%
After a month
6 up, 6 down
typical move ±16.6%
Results releasedNext dayS&P 500 next day5 days21 days
August 13, 2026 −0.1% +0.5% −1.6% −9.3%
May 14, 2026 +10.6% −0.4% +14.5% −29.1%
March 25, 2026 +12.5% −1.2% +10.7% +18.6%
November 12, 2025 +8.6% −1.6% +19.0% +33.0%
August 14, 2025 −1.1% −0.2% −3.8% +5.2%
May 14, 2025 −2.8% +0.6% −2.0% +11.9%
March 31, 2025 −9.3% +1.0% −10.5% +8.8%
November 14, 2024 −13.5% −1.9% −13.0% −14.3%
August 14, 2024 −6.2% +2.0% +1.0% −10.9%
May 15, 2024 +4.6% +1.0% −5.3% −11.0%
March 27, 2024 +23.3% +0.8% +13.6% −9.1%
November 13, 2023 +11.3% +1.8% +21.4% +37.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Dividends, buybacks and capital spending

Diluted share count
+21.5%
year over year

Who owns it

Funds buying and selling
Reported value
$6B
Institutions reporting
274
Shares held vs prior quarter
▲ 16.1%
Positions opened / closed
59 / 59

Top buyers and sellers, Q2 2026: 166 institutions bought and 137 sold ; the biggest buyer was Bank Of America Corp (+757K shares) and the biggest seller Nea Management Company, LLC (−575K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Baker Bros. Advisors LP $828M 7.9M 13.9% 0.0%
Avoro Capital Advisors LLC $356M 3.4M 6.0% ▲ 0.7%
RTW Investments, LP $346M 3.3M 5.8% ▲ 8.7%
Perceptive Advisors LLC $334M 3.2M 5.6% ▲ 2.2%
Blackrock, Inc. $316M 3.0M 5.3% ▲ 11.3%
State Street Corp $205M 2.0M 3.4% ▲ 28.7%
Vanguard Capital Management LLC $196M 1.9M 3.3% ▲ 5.1%
Nea Management Company, LLC $179M 1.7M 3.0% ▼ 25.2%
Soleus Capital Management, L.P. $178M 1.7M 3.0% ▲ 32.7%
Bank Of America Corp $154M 1.5M 2.6% ▲ 106.0%
Deerfield Management Company, L.P. $152M 1.5M 2.5% ▼ 15.3%
Morgan Stanley $140M 1.3M 2.3% ▼ 0.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Celcuity Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $328M 17 trades by 3 insiders · 3% under pre-set plans
Net ▼ $328M net selling
Insider Date Trade Shares Price Value
Baker Julian 10% owner July 14, 2026 Sell 261,368 $102.50 $26.8M
Baker Julian 10% owner July 14, 2026 Sell 2,838,632 $102.50 $291M
Buller Richard E Director May 4, 2026 Sell pre-set plan 365 $143.24 $52,283
Buller Richard E Director May 4, 2026 Sell pre-set plan 1,289 $137.00 $176,593
Buller Richard E Director May 4, 2026 Sell pre-set plan 550 $139.00 $76,450
Buller Richard E Director May 4, 2026 Sell pre-set plan 1,670 $139.58 $233,099
Buller Richard E Director May 4, 2026 Sell pre-set plan 2,301 $141.03 $324,510
Buller Richard E Director May 4, 2026 Sell pre-set plan 2,825 $142.04 $401,263
Dalvey David Director May 4, 2026 Sell pre-set plan 25,000 $140.68 $3.5M
Buller Richard E Director March 31, 2026 Sell pre-set plan 675 $110.83 $74,810
Buller Richard E Director March 31, 2026 Sell pre-set plan 2,325 $110.11 $256,006
Dalvey David Director January 27, 2026 Sell pre-set plan 20,000 $120.03 $2.4M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 4 trades and filings

No trades in Celcuity Inc. disclosed in the last 12 months; 4 earlier trades on record.

  • Tom Malinowski(D-NJ 7):Sale (full), $1,001 - $15,000, traded May 26, 2021, filed June 23, 2021
  • Tom Malinowski(D-NJ 7):Purchase, $1,001 - $15,000, traded June 23, 2020, filed August 26, 2021
  • Tom Malinowski(D-NJ 7):Purchase, $1,001 - $15,000, traded June 22, 2020, filed August 26, 2021

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 11, 2026 estimated from the company's past filing pattern, not announced

  • August 13, 2026
  • May 14, 2026
  • March 25, 2026
  • November 12, 2025
  • August 14, 2025
  • May 14, 2025

Recent SEC filings

Data status

When each part of this page on Celcuity Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Celcuity Inc. in brief

What does Celcuity Inc. do?
Celcuity Inc. is a US-listed company in the biotechnology industry. Its financial year ends in December.
What is Celcuity Inc.'s stock ticker?
Celcuity Inc. trades under the ticker CELC on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
Who are Celcuity Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Baker Bros. Advisors LP, Avoro Capital Advisors LLC and RTW Investments, LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Are insiders buying or selling Celcuity Inc. stock?
Over the last 12 months, Celcuity Inc.'s directors and officers reported 0 open-market purchases and 17 sales on Form 4. The insider trading page charts every trade.
When is Celcuity Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Celcuity Inc. announces its own schedule.